Advertisement
Advertisement
U.S. markets close in 2 hours 30 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Acumen Pharmaceuticals, Inc. (ABOS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
6.01-0.64 (-9.62%)
As of 01:27PM EST. Market open.
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 1/27/2023
Current
9/30/20226/30/20223/31/202212/31/2021
Market Cap (intraday)
225.91M406.25M190.36M158.25M273.58M
Enterprise Value
25.85M216.50M1.47M-35.99M73.62M
Trailing P/E
4.45N/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/A190.51
Price/Book (mrq)
1.151.970.880.701.17
Enterprise Value/Revenue
N/AN/AN/AN/AN/A
Enterprise Value/EBITDA
-0.66-19.11-0.143.921.01

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 338.83%
S&P500 52-Week Change 3-8.00%
52 Week High 310.97
52 Week Low 33.02
50-Day Moving Average 35.72
200-Day Moving Average 35.52

Share Statistics

Avg Vol (3 month) 3102.77k
Avg Vol (10 day) 397.26k
Shares Outstanding 540.93M
Implied Shares Outstanding 6N/A
Float 813.38M
% Held by Insiders 115.57%
% Held by Institutions 177.23%
Shares Short (Jan 12, 2023) 4603.61k
Short Ratio (Jan 12, 2023) 48.27
Short % of Float (Jan 12, 2023) 41.96%
Short % of Shares Outstanding (Jan 12, 2023) 41.47%
Shares Short (prior month Dec 14, 2022) 4875.7k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sep 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-11.24%
Return on Equity (ttm)-17.83%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-12.3M
EBITDA -39.38M
Net Income Avi to Common (ttm)-38.34M
Diluted EPS (ttm)1.55
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)200.19M
Total Cash Per Share (mrq)4.89
Total Debt (mrq)133k
Total Debt/Equity (mrq)0.07
Current Ratio (mrq)30.63
Book Value Per Share (mrq)4.86

Cash Flow Statement

Operating Cash Flow (ttm)-27.59M
Levered Free Cash Flow (ttm)-14.54M
Advertisement
Advertisement